Home Cart Sign in  
Chemical Structure| 482-38-2 Chemical Structure| 482-38-2

Structure of Kaempferitrin
CAS No.: 482-38-2

Chemical Structure| 482-38-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Kaempferitrin can activate insulin signaling pathway, phosphorylate Akt kinase and exert the transloocation of GLUT4, thus has antitumor, antidepressant and antidiabetic effects. Kaempferitrin is a natural product isolated and purified from the root of Kaempferia galangal L..

Synonyms: Lespenephryl; Lespedin; Kaempferol 3,7-bisrhamnoside

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Kaempferitrin

CAS No. :482-38-2
Formula : C27H30O14
M.W : 578.52
SMILES Code : O=C1C(O[C@H](O[C@@H](C)[C@H](O)[C@H]2O)[C@@H]2O)=C(C3=CC=C(O)C=C3)OC4=CC(O[C@H](O[C@@H](C)[C@H](O)[C@H]5O)[C@@H]5O)=CC(O)=C14
Synonyms :
Lespenephryl; Lespedin; Kaempferol 3,7-bisrhamnoside
MDL No. :MFCD01662671
InChI Key :PUPKKEQDLNREIM-QNSQPKOQSA-N
Pubchem ID :5486199

Safety of Kaempferitrin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Kaempferitrin

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SH-SY5Y cells (undifferentiated and differentiated) 5–50 µM 24 hours Evaluation of the protective effect of Kaempferitrin against doxorubicin (Dox)-induced cell damage showed that at 5–50 µM, Krg was ineffective in counteracting Dox-induced cytotoxicity. Int J Mol Sci. 2021 Sep 26;22(19):10363
SH-SY5Y cells (differentiated) 1–50 µM 24 hours Evaluation of the protective effect of Kaempferitrin against 6-OHDA-induced cell damage showed that in differentiated SH-SY5Y cells, Krg did not exhibit significant neuroprotective activity. Int J Mol Sci. 2021 Sep 26;22(19):10363
SH-SY5Y cells (undifferentiated) 1 and 50 µM 24 hours Evaluation of the protective effect of Kaempferitrin against 6-OHDA-induced cell damage showed that at 1 and 50 µM, Krg partially protected undifferentiated SH-SY5Y cells from 6-OHDA-induced toxicity. Int J Mol Sci. 2021 Sep 26;22(19):10363
SH-SY5Y cells (undifferentiated) 50 µM 18 hours Evaluation of the effect of Kaempferitrin on H2O2-induced cathepsin D activity showed that Krg (50 µM) significantly reduced the elevated cathepsin D activity induced by H2O2. Int J Mol Sci. 2021 Sep 26;22(19):10363
SH-SY5Y cells (differentiated) 50 µM 24 hours Evaluation of the protective effect of Kaempferitrin against H2O2-induced cell damage showed that in differentiated SH-SY5Y cells, Krg did not exhibit significant neuroprotective activity. Int J Mol Sci. 2021 Sep 26;22(19):10363
SH-SY5Y cells (undifferentiated) 50 µM 24 hours Evaluation of the protective effect of Kaempferitrin against H2O2-induced cell damage showed that at the highest concentration (50 µM), Krg partially protected undifferentiated SH-SY5Y cells from H2O2-induced damage. Int J Mol Sci. 2021 Sep 26;22(19):10363
SH-SY5Y cells (undifferentiated and differentiated) 50 µM 24 hours Biosafety assessment of Kaempferitrin showed that at the highest tested concentration (50 µM), Krg did not significantly affect the viability of undifferentiated and differentiated SH-SY5Y cells. Int J Mol Sci. 2021 Sep 26;22(19):10363
SH-SY5Y cells (undifferentiated) 5–50 µM 48 and 72 hours Evaluation of the effect of Kaempferitrin on cell proliferation showed that Krg at 5–50 µM had no significant impact on the proliferation rate of undifferentiated SH-SY5Y cells under 10% FBS conditions. Int J Mol Sci. 2021 Sep 26;22(19):10363
rat glomerular mesangial cells (GMCs) 10, 20, 35 μM 24 hours KM effectively increased SOD activity, decreased MDA levels, suppressed ROS generation, and protected against OS in AGE-induced GMCs Int J Mol Sci. 2018 Oct 26;19(11):3334
CHO-K1 cells 100 μM 24 hours Evaluate the effect of KO and KR on PD-1/PD-L1 blockade, results showed that KO and KR blocked PD-1/PD-L1 interaction at non-cytotoxic concentrations Int J Mol Sci. 2020 May 3;21(9):3239
Jurkat T cells 100 μM 24 hours Evaluate the effect of KO and KR on PD-1/PD-L1 blockade, results showed that KO and KR blocked PD-1/PD-L1 interaction at non-cytotoxic concentrations Int J Mol Sci. 2020 May 3;21(9):3239
human small cell lung cancer cells H446 125, 250, 500 µg/mL 48 hours LLF significantly inhibited the proliferation of H446 cells. Biol Res. 2021 Mar 2;54(1):7
human lung cancer A549 cells 125, 250, 500 µg/mL 48 hours LLF significantly inhibited the proliferation of A549 cells, induced apoptosis, upregulated the expression of p38 MAPK, caspase-3, caspase-9, and Bax, and downregulated the expression of Cu/Zn SOD, CAT, Nrf2, NQO1, HO-1, and Bcl-2 via the ROS/p38 MAPK pathway. Biol Res. 2021 Mar 2;54(1):7
HepG2 cells 10 μM 24 hours To study the effect of Kaempferitrin on the secretome of HepG2 cells, it was found that 33 genes were consistently up/down-regulated in two biological samples, and finally 18 genes were screened. Among them, 5 proteins were exosomal markers or reported with high frequency in exosomes/secretory vesicles. In addition, the conditioned medium of Kaempferitrin-treated cells showed increased vesicle size and reduced number of small vesicles. Biomolecules. 2021 Jan 29;11(2):187

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.73mL

0.35mL

0.17mL

8.64mL

1.73mL

0.86mL

17.29mL

3.46mL

1.73mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories